Latest filing published 30 Jun 2023 for Enhabit, Inc., €137k.
Filing timeline
BuySaleFirst 200 filings with a declared amount
Insider track record
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +139.8%Entry US$2.84 · Close at T+365 US$6.81
- +82.7%Entry US$7.88 · Close at T+365 US$14.39
- -58.1%Entry US$11.49 · Close at T+365 US$4.81
- -59.6%Entry US$30.26 · Close at T+365 US$12.24
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
John e. Jr D. D. S. Maupin: trading record in brief
John e. Jr D. D. S. Maupin (board member) discloses dealings in 5 companies, chiefly Regions Financial Corp, Encompass Health Corp and Legacy Lifepoint Health, Inc. Over a trading history stretching from 1 January 2006 to 28 June 2023, the count stands at 288 filings.
In open-market terms, that means 5 purchases worth €47k on one side and 20 sales worth €1.8M on the other. Taken together, the sales exceed the purchases by €1.8M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 122 share grants and 7 option exercises.
Half of the purchases are above €8,857 and half below. After 4 purchases with a full 90-day history, the hit rate stands at 25% and the median 90-day move at -22.0%. They describe history only and say nothing certain about the share price ahead.
Most recently, on 30 June 2023, the filings show a share grant worth €137k in Enhabit, Inc. The last insider purchase was made public on 10 August 2022, 1,552 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to John e. Jr D. D. S. Maupin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,702 shares@ US$11.8191.2% of flowCommon StockSEC:0001803737-23-000115:0
- 1,000 shares@ US$13.598.8% of flowCommon StockSEC:0001803737-22-000092:0Canonical exit: 6 Nov 2022 (T+90)
- 8,246 shares0Common StockSEC:0001803737-22-000062:1
- 6,597 shares0Common StockSEC:0001803737-22-000062:2
- 40,692 shares0Common StockSEC:0001803737-22-000062:0
- 8 shares@ US$72.284.7% of flowEncompass Health Common StockSEC:0001127602-22-012250:1
- 298 shares0Encompass Health Common StockSEC:0001127602-22-012250:0
- 7 shares@ US$61.263.3% of flowEncompass Health Common StockSEC:0001127602-22-001734:1
- 343 shares0Encompass Health Common StockSEC:0001127602-22-001734:0
- 9 shares@ US$66.474.9% of flowEncompass Health Common StockSEC:0001127602-21-027257:1
- 311 shares0Encompass Health Common StockSEC:0001127602-21-027257:0
- 7 shares@ US$80.084.6% of flowEncompass Health Common StockSEC:0001127602-21-022101:1
- 263 shares0Encompass Health Common StockSEC:0001127602-21-022101:0
- 1,757 shares0Encompass Health Common StockSEC:0001127602-21-015991:0
- 7 shares@ US$84.294.7% of flowEncompass Health Common StockSEC:0001127602-21-013958:1
- 247 shares0Encompass Health Common StockSEC:0001127602-21-013958:0
- 244 shares0Encompass Health Common StockSEC:0001127602-21-002091:0
- 5 shares@ US$83.113.3% of flowEncompass Health Common StockSEC:0001127602-21-002091:1
- 9 shares@ US$63.5023.6% of flowEncompass Health Common StockSEC:0001127602-20-027249:1
- 298 shares0Encompass Health Common StockSEC:0001127602-20-027249:0
- 9 shares@ US$63.9919.8% of flowEncompass Health Common StockSEC:0001127602-20-021833:1
- 309 shares0Encompass Health Common StockSEC:0001127602-20-021833:0
- 2,304 shares0Encompass Health Common StockSEC:0001127602-20-015813:0
- 8 shares@ US$69.5317.1% of flowEncompass Health Common StockSEC:0001127602-20-013961:1
- 279 shares0Encompass Health Common StockSEC:0001127602-20-013961:0
25 of 270 declarations